• HOME
  • RESEARCH
    • Biology and dysregulation of IncRNAs
    • Ribosomopathies
    • Epigenetic engineering
    • Engineering cellular immunotherapies
    • Drugging SARS-CoV2 RNA-protein interactions
    • Funding
  • PUBLICATIONS
  • WHO WE ARE
    • Principal Investigator
    • Members
    • Collaborators
    • Alumni
    • Positions Available
    • Lab News
    • Communities
  • MENTORSHIP
  • ENTREPRENEURSHIP
  • CONTACT US
Novina Lab - Engineering Biological Technologies into Therapies

Reunion of Forbeck Scholars

1/31/2018

0 Comments

 
Two former Forbeck Scholars reconnect. Dr. Kim Kelly (University of Virginia) and Dr. Carl Novina establish a new collaboration to evaluate autologous cell therapies for solid tumors.

Picture
0 Comments

Welcome Hyebin Park

1/16/2018

0 Comments

 
Picture
We would like to welcome Hyebin Park, a masters student in Harvard Medical School's Master of Science Immunology program. Hyebin received her Bachelors of Arts in Biological Sciences and Psychology from the University of Chicago. Hyebin will work on developing autologous T cell immunotherapies.

0 Comments

Welcome Leon Wert-Lamas

1/8/2018

0 Comments

 
Picture
We would like to welcome Leon Wert-Lamas PhD, a new postdoctoral fellow who is joining the lab from Institute for Biomedical Research “Alberto Sols“ (Madrid, Spain), where he studied the effects of deregulated non-coding RNAs on thyroid cancer progression and dedifferentiation. Specifically, he evaluated the role of non-coding RNAs in thyroid iodide-metabolizing genes, epithelial-mesenchymal transition and PI3K pathway passenger events. Leon will work on the biological discovery and therapeutic applications of lncRNAs.

0 Comments

Funding Alert!

1/2/2018

0 Comments

 
Picture
Congratulations to Cailin Joyce, PhD (Instructor of Medicine), for her Claudia Adams Barr Award for Innovative Cancer Research! "The Claudia Adams Barr Program in Innovative Basic Cancer Research at Dana-Farber Cancer Institute is widely recognized as one of the largest and most successful programs of its kind. Based on a rigorous and highly selective process, the Claudia Adams Barr Program selects the brightest, most creative scientists and funds their most innovative ideas to propel basic research discoveries that transform cancer treatment."

0 Comments

Funding Alert!

1/2/2018

0 Comments

 
The Novina lab received a $150,000 grant from Curing Kids Cancer to study CAR T cells for the pediatric brain cancer, Diffuse Intrinsic Pontine Glioma!
0 Comments

Congratulations to Novina lab postdocs on their new jobs

1/1/2018

2 Comments

 
In 2017, the Novina lab was tremendously successful in placing postdocs and graduate in high level positions in academia and industry. We would like to congratulate:

  • Johanna Carroll (Assistant Professor, University of Toronto)
  • Glenna Meister (Investigator, Novartis Institute for Biomedical Research)
  • Karyn Schmit (Scientist - Alnylam Pharmaceuticals)
  • Dolly Thomas (Scientist at Rubius Therapeutics)
  • Dhananjay Nawandar (Scientist at Flagship Pioneering Venture Lab)
  • Dustin Griesemer (completed PhD and returned to Harvard Medical School)
2 Comments

    Novina Lab News

    Archives

    July 2021
    May 2021
    February 2021
    January 2021
    December 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    March 2020
    January 2020
    December 2019
    September 2019
    July 2019
    January 2019
    October 2018
    September 2018
    August 2018
    July 2018
    May 2018
    April 2018
    March 2018
    January 2018

    Categories

    All
    Funding
    Lab Updates

    RSS Feed

 HOME | RESEARCH | PUBLICATIONS | WHO WE ARE | MENTORSHIP | ENTREPRENEURSHIP | SUPPORT US | CONTACT US

©2017 Novina Lab at Dana-Farber Cancer Institute